Single-course bleomycin, etoposide, and cisplatin (1xBEP) as adjuvant treatment in testicular nonseminoma clinical stage 1: outcome, safety, and risk factors for relapse in a population-based study
单疗程博来霉素、依托泊苷和顺铂(1xBEP)作为辅助治疗用于临床I期睾丸非精原细胞瘤:一项基于人群的研究的疗效、安全性和复发风险因素
期刊:Therapeutic Advances in Medical Oncology
影响因子:4.2
doi:10.1177/17588359221086813
Dieckmann, Klaus-Peter; Pokrivcak, Tomas; Geczi, Lajos; Niehaus, David; Dralle-Filiz, Inken; Matthies, Cord; Dienes, Tamas; Zschäbitz, Stefanie; Paffenholz, Pia; Gschliesser, Tanja; Pichler, Renate; Mego, Michal; Bader, Pia; Zengerling, Friedemann; Heinzelbecker, Julia; Krausewitz, Philipp; Krege, Susanne; Aurilio, Gaetano; Aksoy, Cem; Hentrich, Marcus; Seidel, Christoph; Törzsök, Péter; Nestler, Tim; Majewski, Matthaeus; Hiester, Andreas; Buchler, Tomas; Vallet, Sonia; Studentova, Hana; Schönburg, Sandra; Niedersüß-Beke, Dora; Ring, Julia; Trenti, Emanuela; Heidenreich, Axel; Wülfing, Christian; Isbarn, Hendrik; Pichlmeier, Uwe; Pichler, Martin